Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Fatigue during the first month often correlates with reduced caloric intake rather than a direct medication effect
Only increase if weight loss stalls for 3 or more consecutive weeks, appetite suppression fades before your next injection, or your prescriber recommends escalation based on your individual progress
Your response to blood sugar regulation may favor one compound over the other
Mounjaro is licensed for the treatment of type 2 diabetes and for weight management
Tirzepatide is a prescription glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist indicated: As an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with a body mass index (BMI) 30 kg/m (obesity), or 27 kg/m (overweight) in the presence of at least one weight-related comorbidity (e.g., hypertension, type 2 diabetes, or dyslipidemia)
US$ 27.04
US$ 28.45
US$ 25.73
US$ 20.60
US$ 21.96
US$ 28.83
US$ 21.96
US$ 23.17
